Final barrier to clear for new bladder cancer tests
Big milestone for company. With special audio feature.
Hot Topic
Rich List
Pacific Edge [NZX: PEB] says it’s confident the company’s bladder cancer test will pass Canterbury District Health Board’s final hurdle with flying colours.
Yesterday, the company’s shares jumped more than 10% on the news that the Canterbury DHB is about to become the first health authority to
Want to read more? It's easy.
Choose your subscription
Already have an account? Login
Smartphone Only Subscription
NZ$29.95 / monthly
Monthly Premium Online Subscription
NZ$49.95 / monthly
Smartphone Only Annual Subscription
NZ$299.00 / yearly
Yearly Premium Online Subscription
NZ$499.00 / yearly
Premium Group Membership 10 Users
NZ$385+GST / monthly
$38.5 per user - Pay by monthly credit card debitPremium Group Membership 20 Users
NZ$660+GST / monthly
$33 per user - Pay by monthly credit card debitPremium Group Membership 50 Users
NZ$1375+GST / monthly
$27.5 per user - Pay by monthly credit card debitPremium Group Membership 100 Users
NZ$2100+GST / monthly
$21 per user - Pay by monthly credit card debitYearly Premium Online Subscription + NBR Marketplace
NZ$999.00 / yearly
Individual
Group membership
NBR Marketplace
Jenny Ruth
Thu, 10 Mar 2016
Thu, 10 Mar 2016
© All content copyright NBR. Do not reproduce in any form without permission, even if you have a paid subscription.
Free News Alerts
Sign up to get the latest stories and insights delivered to your inbox – free, every day.
Related News
Free News Alerts
Sign up to get the latest stories and insights delivered to your inbox – free, every day.
Related News
Final barrier to clear for new bladder cancer tests
56322